Cedars-Sinai Health Sciences University investigators developed an AI-based model that can identify hospitalized patients at risk of low blood sugar up to 24 hours before the condition occurs
Associate Professor Hyun-Do Jung from Hanyang University and his team, based in Korea, have now developed an artificial intelligence (AI)-guided microneedle patch that actively changes shape at physiological temperature (37°C) to help close wounds while delivering regenerative therapy and antibacterial protection.
First Read aims to address interpretation bottlenecks by producing preliminary, high-quality report drafts.
Now, new AI-aided vaccine technology developed by scientists at Cambridge University offers potential immunity against whole families of viruses and could even prevent the next pandemic, according to researchers.
Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers scientists’ expertise to find viable target antigens for CAR T cell therapy.
This authorisation will expand the B-Right AI platform’s use to Europe, as BrightHeart continues to roll the technology out across the US.
With a new tool that could transform how that game is played, UC Berkeley researchers have discovered a previously unrecognized signal in electrocardiograms that can better detect high-risk patients before their hearts stop.
Decision delivers the first ADC-based regimens for previously untreated triple-negative breast cancer across PD-L1 status, a PD-L1-positive Keytruda combination plus a monotherapy option for immunotherapy-ineligible patients.
A tiny silk sticker that visibly shows vital health signals, read by an AI system, could change how we care for the tiniest patients
Spotlight Medical, a Paris-based oncology diagnostics company, has announced that myStage Dx has received CE marking under the European Union In Vitro Diagnostic Medical Devices Regulation (IVDR, Regulation (EU) 2017/746).